Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Jan 17, 2024 3:53pm
59 Views
Post# 35832081

RE:What is the market pricing?

RE:What is the market pricing?The market doesn't have much to go on at this point. 

Ronnie Miller is "thrilled": “We are thrilled with this exciting transaction..."

Gilles is "excited" and he has a view inside of AEZS and CZO: "This is an exciting day for stakeholders of both companies who share a bright future together.”

Carolyn Egbert, Chair of Aeterna, "believes the transaction announced today presents a compelling upside opportunity for investors in both companies...”

Bloom Burton and Raymon James have provided fairness opinions.

Based on H.C. Wainwrights UC$15 target and that it is a merger of equals it could arguably be seen as a C$200 million combined company over the next year.

More details are expected to be released at the end of the month. When the terms of the diagnostic deal and a PGX deal are released we will know a bunch more. That Gilles wants to move CZO to the NASDAQ ahead of events is promising. Ronnie is "thrilled".


Stinzo wrote: Is it pricing that the merger takes place? If that's the case the market is saying the new Company is going to 0

Is it pricing that the merger doesn't take place? If that's the case, it's assuming Gilles can't be kicked out or no considerable investor is willing to take CZO over

I feel very sorry for all the lost money I have put into this company 


<< Previous
Bullboard Posts
Next >>